Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212641 · ClinicalTrials.gov registry record · Phase 2
A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus
A Phase 2 study, sponsored by Ono Pharma USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT00212641 is a Phase 2 study that has completed, run by Ono Pharma USA. The registered enrollment target is 105 participants.
The verdict
NCT00212641, a Phase 2 study, has completed, sponsored by Ono Pharma USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
The objectives of this study are to characterize the pharmacodynamic profile, safety and tolerability of ONO-5129 in patients with Type 2 Diabetes mellitus
Interventions
- DRUG ONO-5129
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00212641
The ClinicalTrials.gov registry entry for NCT00212641 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ono Pharma USA, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ONO-5129 is the first listed.
NCT00212641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00212641 about?
NCT00212641 is a clinical study titled "A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus". The objectives of this study are to characterize the pharmacodynamic profile, safety and tolerability of ONO-5129 in patients with Type 2 Diabetes mellitus
What is the current status of trial NCT00212641?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2005-06.
What interventions are being tested in trial NCT00212641?
The interventions under investigation include: ONO-5129 (DRUG).
Who is sponsoring clinical trial NCT00212641?
This trial is sponsored by Ono Pharma USA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.